Tower Research Capital LLC (Trc) Abeona Therapeutics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,951 shares of ABEO stock, worth $35,825. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,951
Previous 5,989
0.63%
Holding current value
$35,825
Previous $37,000
10.81%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ABEO
# of Institutions
66Shares Held
28.3MCall Options Held
593KPut Options Held
18K-
Adage Capital Partners Gp, L.L.C. Boston, MA3.9MShares$23.5 Million0.04% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.69MShares$22.2 Million0.85% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.53MShares$21.2 Million0.98% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.12MShares$12.7 Million0.01% of portfolio
-
Western Standard LLC Los Angeles, CA2.08MShares$12.5 Million7.9% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $35.8M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...